Good scientists reveal how they do their experiments and report their results; so should any machine-driven research ...

Arren Bar-Even drove a new way to engineer metabolism; his former collaborators and students are continuing the work ...

Mouse and human data hint that biological differences may shape drug bioavailability in ways clinical trials often overlook ...

No matter how well you plan, you never know when disaster will strike and render all those plans useless. When that happens, giving up can seem like the best option—but it rarely is. You can take ...

C&EN business editor Michael McCoy, at m_mccoy@acs.org. The activist investor Ancora Holdings is pushing Ashland to put itself up for sale. Ashland was once a diversified chemical giant, but ...

Lithium has reigned in the battery world for decades. Researchers have tried for years to make a cheaper, more sustainable successor to lithium-ion batteries by using the element’s more common ...

Our contributor recalls his first international collaboration and how tools of communication have changed in an increasingly ...

The US is getting a new sunscreen ultraviolet (UV) filter for the first time in 30 years. On June 9, the US Food and Drug ...

Under pressure from activists and state environmental authorities, Freepoint Eco-Systems has suspended operations at its new ...

Athletes have been using classic glycogen-loading routines since the 1960s. They essentially boost consumption of ...

The work proves that embryo editing is far from a clinical reality. But the experiment has sparked controversy nonetheless ...

Evonik Industries, one of the largest chemical producers in Germany, is reorganizing its research and development (R&D) ...